Rosa Marina Melillo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Small Cell Lung Cancer

Top Venues

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Federica Liotti, Maria Marotta, Daniela Sorriento, Chiara Pagliuca, Valeria Caturano, Giuseppe Mantova, Elena Scaglione, Paola Salvatore, Rosa Marina Melillo, Nella Prevete
Probiotic Lactobacillus rhamnosus GG (LGG) restrains the angiogenic potential of colorectal carcinoma cells by activating a proresolving program via formyl peptide receptor 1. Molecular oncology 16 (16) (2022)
Maria Rosaria Ambrosio, Giusy Mosca, Teresa Migliaccio, Domenico Liguoro, Gisella Nele, Fabrizio Schonauer, Francesco D'Andrea, Federica Liotti, Nella Prevete, Rosa Marina Melillo, Carla Reale, Concetta Ambrosino, Claudia Miele, Francesco Beguinot, Vittoria D'Esposito, Pietro Formisano
Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines. Cancers 14 (21) (2022)
Federica Liotti, Maria Marotta, Rosa Marina Melillo, Nella Prevete
The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression. Cancers 14 (14) (2022)
Federica Liotti, Maria Marotta, Daniela Sorriento, Emanuela Pone, Francesco Morra, Rosa Marina Melillo, Nella Prevete
Toll-Like Receptor 7 Mediates Inflammation Resolution and Inhibition of Angiogenesis in Non-Small Cell Lung Cancer. Cancers 13 (4) (2021)
Federica Liotti, Nella Prevete, Giancarlo Vecchio, Rosa Marina Melillo
Recent advances in understanding immune phenotypes of thyroid carcinomas: prognostication and emerging therapies. F1000Research 8 (2019)
Francesca Collina, Lucia La Sala, Federica Liotti, Nella Prevete, Elvira La Mantia, Maria Grazia Chiofalo, Gabriella Aquino, Laura Arenare, Monica Cantile, Giuseppina Liguori, Francesca Di Gennaro, Luciano Pezzullo, Nunzia Simona Losito, Giancarlo Vecchio, Gerardo Botti, Rosa Marina Melillo, Renato Franco
AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer. Cancers 11 (6) (2019)